Health-related quality of life and associated risk factors in patients with Multiple Osteochondromas: a cross-sectional study
-
Published:2024-03-08
Issue:5
Volume:33
Page:1323-1334
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Boarini Manila, Tremosini Morena, Di Cecco Alessia, Gnoli Maria, Brizola Evelise, Mordenti Marina, Pedrini Elena, Locatelli ManuelaORCID, Lanza Marcella, Antonioli Diego, Gallone Giovanni, Rocca Gino, Staals Eric L., Trisolino Giovanni, Sangiorgi Luca
Abstract
Abstract
Purpose
To evaluate the health-related quality of life and associated risk factors for Multiple Osteochondromas patients.
Methods
A cross-sectional, observational study was conducted from May to December 2022 during the routine visit to the referral center for rare skeletal disorders. All patients with Multiple Osteochondromas aged ≥ 3 years were included. EuroQol 5-dimension questionnaires, and demographic, clinical, and surgical history data were collected. Descriptive statistics, Fisher’s exact test, One-sample t-test, Spearman’s correlation, and multiple linear and logistic regression were performed to analyze the data. Results are reported following STROBE guidelines.
Results
A total of 128 patients were included in the study, with a mean age of 14 [SD, 10] years. The mean EQ-5D Index Value was 0.863 [SD, 0.200] and the EQ-VAS was 84 [SD, 19] with a positive correlation between two scores [r = 0.541, p < 0.001]. Patients frequently referred problems in pain/discomfort [78.8%], anxiety/depression [50%], and usual activities [38.8%] dimensions. Increasing age was the common risk factor for health-related quality of life [p < 0.000], as well as Index Value and VAS scores were significantly lower in surgical patients [p = 0.001 and p < 0.001, respectively].
Conclusion
Increasing age and surgical procedures were found highly associated with reduced health-related quality of life in Multiple Osteochondromas patients. Our findings provide relevant information to support the establishment of patient-centered healthcare pathways and pave the way for further research into medical and non-medical therapeutic strategies for these patients.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Ferreira, C. R. (2019). The burden of rare diseases. American Journal of Medical Genetics Part A, 179(6), 885–892. https://doi.org/10.1002/ajmg.a.61124 2. Haendel, M., Vasilevsky, N., Unni, D., Bologa, C., Harris, N., Rehm, H., Hamosh, A., Baynam, G., Groza, T., McMurry, J., & Dawkins, H. (2020). How many rare diseases are there? Nature Reviews. Drug Discovery, 19(2), 77–78. https://doi.org/10.1038/d41573-019-00180-y 3. Stoller, J. K. (2018). The challenge of rare diseases. Chest, 153(6), 1309–1314. https://doi.org/10.1016/j.chest.2017.12.018 4. Schieppati, A., Henter, J. I., Daina, E., & Aperia, A. (2008). Why rare diseases are an important medical and social issue. The Lancet, 371(9629), 2039–2041. https://doi.org/10.1016/S0140-6736(08)60872-7 5. von der Lippe, C., Diesen, P. S., & Feragen, K. B. (2017). Living with a rare disorder: A systematic review of the qualitative literature. Molecular Genetics & Genomic Medicine, 5(6), 758–773. https://doi.org/10.1002/mgg3.315
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|